Gliatilin injection 1000mg/4ml 3 vials

Gliatilin (Cholini alfosceras, Choline alfoscerate) - central cholinomimetic action with a primary effect on the central nervous system. It has a neuroprotective effect. Choline release takes place in the brain; Choline is involved in the biosynthesis of acetylcholine (one of the main mediators of nerve excitation). Alfostserat biotransformed to glycerophosphate, which is a precursor of phospholipids.

Gliatilin improves the transmission of nerve impulses in the cholinergic neurons; positive effect on the plasticity and neuronal membrane receptor function. Increases cerebral blood flow, enhances metabolic processes and activates the brain structure of the reticular formation and restores consciousness in traumatic brain damage.

It has a preventive and a corrective effect on the factors of involution psychoorganic syndrome, such as changing the composition of phospholipid membranes of neurons and decreased cholinergic activity.

In experimental studies have shown that Gliatilin stimulates a dose-dependent release of acetylcholine in physiological conditions, the transmission of nerve impulses.

It increases acetylcholine synthesis and positively affects the transmission of nerve impulses, and glycerophosphate involved in the synthesis of phosphatidylcholine (phospholipid membrane) to improve the elasticity of the membrane and the function of receptors.

Drug Interactions drug Gliatilin not established.

Indications:

• The acute period of craniocerebral trauma mainly stem lesions (including the violation of consciousness, coma).
• Violations of the cerebral circulation on ischemic and hemorrhagic type (in the acute and recovery period).
• Degeneration and involution syndromes and consequences of psycho-organic cerebrovascular disease, such as primary and secondary disturbances mnemonic functions, characterized by memory impairment, confusion, disorientation, decreased motivation, initiative and ability to concentrate.
• Changes in emotional and behavioral sphere: emotional instability, irritability, decreased interest.
• Senile psevdomelanholiya.

Suggested Use:

For adults, in acute conditions: a / m - 1000 mg / day (1 ampoule) or / - 1000-3000 mg / day. With on / in a content of 1 vial (4 ml) was diluted in 50 ml saline infusion rate - 60-80 drops per minute. Duration of treatment - usually 10 days, but if necessary, treatment can be continued until the positive dynamics and the possibility to go to a reception inside capsules.

Effects on ability to drive vehicles and management mechanisms Gliatilin does not affect the patient's ability to engage in potentially hazardous activities.

Packaging:

• Comes in original packaging. Item is brand new and unopened.

Storage:

• Keep away from direct sunlight.
• Keep locked and away from children.
• Store in dry place at room temperature.
• Do not exceed storage temperature higher than 25 C

Important notice- the outer box design may vary before prior notice!